Back
Pliant Therapeutics Stock Price Chart
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Buy
52
PLRX
Pliant Therapeutics
Last Price:
13.83
Seasonality Move:
15.67%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!- The current trend is moderately bearish and PLRX is experiencing selling pressure, which indicates risk of future bearish movement.
Pliant Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.8 | Sell |
| 20-day SMA: | 14.59 | Sell |
| 50-day SMA: | 13.03 | Buy |
| 200-day SMA: | 13.56 | Buy |
| 8-day EMA: | 14.81 | Sell |
| 20-day EMA: | 14.31 | Buy |
| 50-day EMA: | 13.51 | Buy |
| 200-day EMA: | 13.84 | Buy |
Pliant Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.59 | Buy |
| Relative Strength Index (14 RSI): | 54.13 | Buy |
| Chaikin Money Flow: | -311916 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.77 - 15.31) | Buy |
| Bollinger Bands (100): | (11.38 - 14.06) | Buy |
Pliant Therapeutics Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Pliant Therapeutics Stock
Is Pliant Therapeutics Stock a Buy?
- Pliant Therapeutics share price is 14.53 while PLRX 8-day simple moving average is 14.80, which is a Sell signal.
- The stock price of PLRX is 14.53 while Pliant Therapeutics 20-day SMA is 14.59, which makes it a Sell.
- Pliant Therapeutics 50-day simple moving average is 13.03 while PLRX share price is 14.53, making it a Buy technically.
- PLRX stock price is 14.53 and Pliant Therapeutics 200-day simple moving average is 13.56, creating a Buy signal.
PLRX Technical Analysis vs Fundamental Analysis
Buy
52
Pliant Therapeutics (PLRX)
is a Buy
Is Pliant Therapeutics a Buy or a Sell?
-
Pliant Therapeutics stock is rated a Buy
The current Pliant Therapeutics [PLRX] share price is $14.53. The Score for PLRX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Pliant Therapeutics Stock Info
Market Cap:
884.2M
Price in USD:
14.53
Share Volume:
326.42K
Pliant Therapeutics 52-Week Range
52-Week High:
19.62
52-Week Low:
10.22
Buy
52
Pliant Therapeutics (PLRX)
is a Buy
Pliant Therapeutics Share Price Forecast
-
What is the Pliant Therapeutics stock price today?
The Pliant Therapeutics stock price is 14.53 USD today. -
Will PLRX stock go up or go down?
Pliant Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Pliant Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pliant Therapeutics is not overvalued.
Is Pliant Therapeutics Stock a Buy?
- Pliant Therapeutics share price is 14.53 while PLRX 8-day exponential moving average is 14.81, which is a Sell signal.
- The stock price of PLRX is 14.53 while Pliant Therapeutics 20-day EMA is 14.31, which makes it a Buy.
- Pliant Therapeutics 50-day exponential moving average is 13.51 while PLRX share price is 14.53, making it a Buy technically.
- PLRX stock price is 14.53 and Pliant Therapeutics 200-day simple moving average is 13.84, creating a Buy signal.
Fundamental Analysis of Pliant Therapeutics
Is Pliant Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.74 per share, and a decrease next year of $0.31 per share.
Technical Analysis of Pliant Therapeutics
Should I short Pliant Therapeutics stock?
- PLRX Moving Average Covergence Divergence (MACD) indicator is 0.59, suggesting Pliant Therapeutics is a Buy
- Pliant Therapeutics Relative Strength Index (RSI) is 54.13, which suggest Pliant Therapeutics is overbought
- The Bollinger Bands (25) for Pliant Therapeutics is (12.77 - 15.31), which suggest Pliant Therapeutics is a Buy
- The Bollinger Bands (100) for Pliant Therapeutics is (11.38 - 14.06), which suggest Pliant Therapeutics is a Buy
* Pliant Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.